301075.SZ
多瑞医药
SZSE · C 制造业 · CN
CNY 53.75
+0.09%Sep 3, 2026, 12:36 UTC
Duorui Pharmaceutical and its subsidiary Wuhan Jirui Health Industry Investment Co., Ltd. signed agreements to transfer 51% of Quanruinuo and 3.39% of Kairuipu to related party Tibet Jiakang Shidai Technology Development Co., Ltd. for 4.4047 million yuan and 5 million yuan respectively.
Source:Aug 25, 2026, 11:51 UTC
Duorui Pharmaceutical announced the transfer of its 100% equity in subsidiary Hubei Duorui Pharmaceutical to shareholder Tibet Jiakang Times Technology Development for 77.2645 million yuan, constituting a related-party transaction.
Source:Aug 25, 2026, 11:50 UTC
Duorui Pharmaceutical announced its first-half 2026 results: net profit attributable to shareholders was 11.5294 million yuan, turning from a loss of 42.5036 million yuan in the same period last year.
Source: